Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold S Lippa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|October 7, 2004
Anxioselective anxiolytics: can less be more?Anthony S Basile, Arnold S Lippa, Phil Skolnick
Anticancer Research|December 27, 2017
Oncolytic Properties of Ampakines <i>In Vitro</i>Daniel P Radin, Richard Purcell, Arnold S Lippa
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2018
Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brainDaniel P Radin, Steven Johnson, Richard Purcell, et al.
European Journal of Pharmacology|February 15, 2003
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitorPhil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Current Protocols in Pharmacology|February 2, 2012
Animal tests of anxietySandra E File, Arnold S Lippa, Bernard Beer, et al.
Life Sciences|October 17, 2003
"Broad spectrum" antidepressants: is more better for the treatment of depression?Phil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Current Protocols in Neuroscience|April 23, 2008
Animal tests of anxietySandra E File, Arnold S Lippa, Bernard Beer, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2006
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptorsPiotr Popik, Emmanuel Kostakis, Martyna Krawczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2007
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painAnthony S Basile, Aaron Janowsky, Krystyna Golembiowska, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|October 7, 2004
Anxioselective anxiolytics: can less be more?Anthony S Basile, Arnold S Lippa, Phil Skolnick
Anticancer Research|December 27, 2017
Oncolytic Properties of Ampakines <i>In Vitro</i>Daniel P Radin, Richard Purcell, Arnold S Lippa
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2018
Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brainDaniel P Radin, Steven Johnson, Richard Purcell, et al.
European Journal of Pharmacology|February 15, 2003
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitorPhil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Current Protocols in Pharmacology|February 2, 2012
Animal tests of anxietySandra E File, Arnold S Lippa, Bernard Beer, et al.
Life Sciences|October 17, 2003
"Broad spectrum" antidepressants: is more better for the treatment of depression?Phil Skolnick, Piotr Popik, Aaron Janowsky, et al.
Current Protocols in Neuroscience|April 23, 2008
Animal tests of anxietySandra E File, Arnold S Lippa, Bernard Beer, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2006
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptorsPiotr Popik, Emmanuel Kostakis, Martyna Krawczyk, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2007
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic painAnthony S Basile, Aaron Janowsky, Krystyna Golembiowska, et al.
Pageof 1